| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | -0.087 | 0.009 |
| mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | -0.087 | 0.01 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | -0.087 | 0.01 |
| mRNA | LFM-A13 | GDSC1000 | pan-cancer | AAC | -0.087 | 0.01 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | -0.083 | 0.01 |
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | -0.1 | 0.01 |
| mRNA | AMG-706 | FIMM | pan-cancer | AAC | -0.42 | 0.01 |
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | -0.098 | 0.01 |
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | -0.085 | 0.01 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.085 | 0.01 |